Overseas sales drive growth at Tristel
Infection control specialist Tristel has reported revenue growth of 10.9% to £5.1m for the six months to 31 December 2011, driven by overseas sales.
Sales in China and Germany and a launch into the Australian hospital market pushed overseas sales up by more than 100% to £775,000.
“All these new activities are still in their infancy and we can expect substantial contributions from them in the future,” said Tristel’s chief executive Paul Swinney.
Pre-tax profit fell to £262,000 from £433,000.
Swinney added: “We have now levelled off our investment in people and overheads and as we continue to grow sales in the areas we invested in last year we will see a significant improvement in profitability.”
Tristel is now fully engaged in the manufacture and sale of disinfectants and cleaning products in three markets: hospital infection control; animal healthcare (mainly veterinary practices) and manufacturers of pharmaceutical and personal care products for contamination control in their manufacturing processes.
Subscribe now to Cleanroom Technology to get unrestricted online access to our exclusive content and receive our high quality magazine every month.